Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
2.500
-0.030 (-1.19%)
At close: Nov 19, 2025, 4:00 PM EST
2.530
+0.030 (1.20%)
Pre-market: Nov 20, 2025, 8:08 AM EST
Invivyd Employees
As of December 31, 2024, Invivyd had 100 total employees, including 99 full-time and 1 part-time employees. The number of employees increased by 5 or 5.26% compared to the previous year.
Employees
100
Change (1Y)
5
Growth (1Y)
5.26%
Revenue / Employee
$500,390
Profits / Employee
-$598,620
Market Cap
582.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 100 | 5 | 5.26% |
| Dec 31, 2023 | 95 | 9 | 10.47% |
| Dec 31, 2022 | 86 | -17 | -16.50% |
| Dec 31, 2021 | 103 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IVVD News
- 1 day ago - Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination - Seeking Alpha
- 2 days ago - Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 2 days ago - Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 days ago - Invivyd Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 13 days ago - Invivyd, Inc. (IVVD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 16 days ago - Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025 - GlobeNewsWire
- 20 days ago - Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID Prevention Transcript - Seeking Alpha